Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

The burden of chronic obstructive pulmonary disease among employed adults

Authors DiBonaventura MD, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, Shah H

Received 17 December 2011

Accepted for publication 26 January 2012

Published 19 March 2012 Volume 2012:7 Pages 211—219

DOI https://dx.doi.org/10.2147/COPD.S29280

Review by Single-blind

Peer reviewer comments 2

Marco daCosta DiBonaventura1, Ryne Paulose-Ram2, Jun Su3, Margaret McDonald2, Kelly H Zou2, Jan-Samuel Wagner1, Hemal Shah3

1Health Sciences Practice, Kantar Health, New York, NY, USA; 2Pfizer, Inc, New York, NY, USA; 3Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA

Objective: To examine quality of life, work productivity, and health care resource use among employed adults ages 40–64 years with chronic obstructive pulmonary disease (COPD) in the United States.
Methods: Data from the 2009 National Health and Wellness Survey were used. All employed adults ages 40–64 years with or without a self-reported diagnosis of COPD were included in the study. Impact on quality of life (using the mental and physical component summary scores and health utilities from the Short Form-12v2), work productivity and activity impairment (using the Work Productivity and Activity Impairment questionnaire), and resource use were analyzed using regression modeling.
Results: There were 1112 employed adults with COPD versus 18,912 employed adults without COPD. After adjusting for demographics and patient characteristics, adults with COPD reported significantly lower mean levels of mental component summary (46.8 vs 48.5), physical component summary (45.6 vs 49.2), and health utilities (0.71 vs 0.75) than adults without COPD. Workers with COPD reported significantly greater presenteeism (18.9% vs 14.3%), overall work impairment (20.5% vs 16.3%), and impairment in daily activities (23.5% vs 17.9%) than adults without COPD. Employed adults with COPD also reported more mean emergency room visits (0.21 vs 0.12) and more mean hospitalizations (0.10 vs 0.06) in the previous 6 months than employed adults without COPD. All of the above differences were significant at two-sided P < 0.05.
Conclusion: After adjusting for various confounders, employed adults with COPD reported significantly lower quality of life and work productivity, and increased health care resource utilization than employed adults without COPD. These results highlight the substantial impact and burden of COPD in the United States workforce.

Keywords: chronic obstructive pulmonary disease, quality of life, work productivity, activities of daily living, health care resource use

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

The association between lower back pain and health status, work productivity, and health care resource use in Japan

Sadosky AB, DiBonaventura M, Cappelleri JC, Ebata N, Fujii K

Journal of Pain Research 2015, 8:119-130

Published Date: 25 February 2015

The burden of insomnia in Japan

Mishima K, DiBonaventura MD, Gross H

Nature and Science of Sleep 2015, 7:1-11

Published Date: 5 January 2015

Impact of middle-of-the-night awakenings on health status, activity impairment, and costs

Moline M, DiBonaventura MD, Shah D, Ben-Joseph R

Nature and Science of Sleep 2014, 6:101-111

Published Date: 23 July 2014

The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogs

DiBonaventura M, Wintfeld N, Huang J, Goren A

Patient Preference and Adherence 2014, 8:873-882

Published Date: 19 June 2014

Characteristics, treatment patterns, and unmet needs of Japanese patients with atrial fibrillation [Corrigendum]

Koretsune Y, Rossi B, Iwamoto K, Wang ECY, DiBonaventura M, Briere JB

Research Reports in Clinical Cardiology 2014, 5:41-42

Published Date: 29 January 2014

Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia [Corrigendum]

Kinoshita Y, DiBonaventura M, Rossi B, Iwamoto K, Wang ECY, Briere JB

Clinical and Experimental Gastroenterology 2013, 6:193-194

Published Date: 23 September 2013

Characteristics, treatment patterns, and unmet needs of Japanese patients with atrial fibrillation

Koretsune Y, Rossi B, Iwamoto K, Wang ECY, DiBonaventura M, Briere JB

Research Reports in Clinical Cardiology 2013, 4:97-105

Published Date: 4 July 2013

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom

DiBonaventura MD, Chandran A, Hsu MA, Bushmakin A

International Journal of Women's Health 2013, 5:261-269

Published Date: 24 May 2013

Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia

Kinoshita Y, DiBonaventura M, Rossi B, Iwamoto K, Wang ECY, Briere JB

Clinical and Experimental Gastroenterology 2013, 6:51-59

Published Date: 20 May 2013

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom

DiBonaventura MD, Prior M, Prieto P, Fortea J

Clinical and Experimental Gastroenterology 2012, 5:203-212

Published Date: 8 November 2012

Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication

Marco daCosta DiBonaventura, Jan-Samuel Wagner, Cynthia J Girman, et al

Patient Preference and Adherence 2010, 4:397-406

Published Date: 3 November 2010

Readers of this article also read:

The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease

Takeda K, Kawasaki Y, Yoshida K, Nishida Y, Harada T, Yamaguchi K, Ito S, Hashimoto K, Matsumoto S, Yamasaki A, Igishi T, Shimizu E

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:347-351

Published Date: 23 July 2013

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland

Samyshkin Y, Schlunegger M, Haefliger S, Ledderhose S, Radford M

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:79-87

Published Date: 30 January 2013

The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease

Decramer ML, Hanania NA, Lötvall JO, Yawn BP

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:53-64

Published Date: 25 January 2013

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease

Ito K, Colley T, Mercado N

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:641-652

Published Date: 21 September 2012

The importance of knowing the home conditions of patients receiving long-term oxygen therapy

Godoy I, Tanni SE, Hernández C, Godoy I

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:421-425

Published Date: 5 July 2012

Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients

Make B, Dutro MP, Paulose-Ram R, Marton JP, Mapel DW

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:1-9

Published Date: 18 January 2012

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology

Wilson R, Anzueto A, Miravitlles M, Arvis P, Faragó G, Haverstock D, Trajanovic M, Sethi S

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:373-383

Published Date: 29 June 2011